Nw-Hydroxy L-Arginine (NOHA): A Promising Biomarker of Response to Neoadjuvant Therapy in the Management of Triple Negative Breast Cancer
{{output}}
Background: Oncologists lack effective point-of-care biomarkers to rapidly adapt curative-intent triple negative breast cancer (TNBC) neoadjuvant therapy (NT). Previous work reveals that Nw-hydroxy-L-Arginine (NOHA) is an easily ... ...
